SND1-IT1: A Protein Regulator of Neural Crest Cell and Pain Perception

Target Name: SND1-IT1

NCBI ID: G27099

SND1-IT1

Other Name(s): NSG-X | NAG8 | SND1 intronic transcript 1 | C7orf54

SND1-IT1: A Protein Regulator of Neural Crest Cell and Pain Perception

SND1-IT1 (NSG-X) is a protein that is expressed in various tissues throughout the body, including the nervous system, endocrine system, and muscle system. It is a key regulator of the neural crest cell (NCC), a type of stem cell that gives rise to a variety of tissues, including nerve cells.

The NCC is a crucial part of the development and maintenance of the nervous system, and SND1-IT1 plays a vital role in this process. During embryonic development, the NCC helps to give rise to the nervous system, including the brain and spinal cord. As the NCC matures, it continues to function as a source of stem cells for the nervous system, ensuring that the brain and spinal cord are able to adapt and grow throughout life.

SND1-IT1 is also involved in the regulation of cell proliferation and differentiation. It helps to control the number of cells that have the ability to divide and grows in response to different stimuli. This is important for the development and maintenance of tissues, including muscles and bones.

In addition to its role in cell proliferation and differentiation, SND1-IT1 is also involved in the regulation of pain perception. It is thought to play a key role in the development of pain and in the modulation of pain sensitivity. This is important for our overall well-being, as pain can be a sign of underlying injury or illness and can be a source of discomfort and suffering.

SND1-IT1 is also a potential drug target for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. It is currently being investigated as a potential therapeutic agent for a variety of these conditions, including multiple sclerosis, rheumatoid arthritis, and neuroimmune disorders.

In addition to its potential therapeutic applications, SND1-IT1 is also an important biomarker for the diagnosis and monitoring of various diseases. Its expression has been observed in a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This makes it a valuable tool for the diagnosis and research of these conditions.

Overall, SND1-IT1 is a protein that plays a vital role in the development and maintenance of the nervous system, and is being actively investigated as a potential drug target and biomarker for a variety of diseases. Further research is needed to fully understand its functions and potential therapeutic applications.

Protein Name: SND1 Intronic Transcript 1

The "SND1-IT1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SND1-IT1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets